Believe it or not, there's something worse than male pattern baldness. It's depression, plunging libido and shrinking ...

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...

Few men want a receding hairline or a “thinning crown”, but luckily there’s a wide range of effective solutions to help you stave them off. Hims UK is a men’s wellness brand that has ...

Hims & Hers is shutting down the dermatology business it acquired in 2021, BI has learned. It said it's closing the skincare site Apostrophe to centralize its teledermatology offerings. Hims ...

Hims & Hers Health ( NYSE: HIMS) shut down Apostrophe on Friday, the skincare business it acquired in 2019 for $190M. A ...

Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...

Hims is a telehealth company that offers a variety of online services tailored to men, including treatments for hair loss and erectile dysfunction, primary care, and more. Through the company ...

Hims & Hers is shutting down the dermatology business it acquired four years ago, Business Insider has learned. On Friday, the telehealth company discontinued Apostrophe, the direct-to-consumer ...

Read Our Latest Research Report on HIMS Hims & Hers Health Stock Up 4.7 % Shares of NYSE HIMS opened at $36.01 on Friday. Hims & Hers Health, Inc. has a 52 week low of $11.20 and a 52 week high of ...